Submission of the unaudited financial results for Quarter and half year ended, 30th September, 2025 Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a Statement of Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2025 along with Limited Review Report submitted by the Statutory Auditors of the Company. The above financial results were upon recommendation of the Audit Committee approved by the Board of Directors at its meeting held on November 14th, 2025. The meeting of the Board of Directors of the Company commenced at 4:00 p.m. and concluded at 5:00 p.m. Kindly take the same on your record. We request you to inform your members accordingly.. PULINDRA PATEL & CO. CHARTERED ACCOUNTANTS Office No. A-1004, Paras Business Center, Kasturba Road No.1, Near Borivali Station East, Borivali East, Mumbai — 400 066, " Office (Tel) +022-28069664,022-22056233,022-68844594,+91-9322268243,0ffice (M) +91-9619908533 / Email : caoffice@pulindrapatel.com, pulindra_patel@hotmail.com Independent Auditor’s Review Report on the Standalone Unaudited Quarterly Financial Results and Year to Date Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) To, The Board of Directors, Caprolactam Chemicals Limited Plot No. B-31, M.I.D.C.- Mahad, Taluka — Mahad, Dist Raigad — 402302. We have reviewed the quarterly unaudited standalone financial results of M/S.CAPROLACTAM CHEMICALS LIMITED (the company) for the, Quarter and half yearly ended September 30, 2025 (the Statement™) together with the Unaudited Satement of Assets and Liabilities, Unaudited Statement of Cas Flows attached herewith, being submitted by the company pursuant to the requirement of Regulation 33 of the SEBI (Listing obligations and Disclosure Requirements) Regulations 2015 as amended ( “Listing Regulations™). This statement which is the responsibility of the Company’s Management and has been approved by the Board of Directors has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting” (Ind AS 34), prescribed under section 133 of the Companies Act, 2013 read with relevant rules issued there under and other accounting principles generally accepted in India. Our responsibility is to issue a report on the statement based on our review. We conducted our review of the Statement in accordance with the standard on Review Engagement (SRE) 2410 ‘Review of Interim Financial Information performed by the Independent Auditor of the Entity’ issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statement is free of material misstatements. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. Based on our review conducted as stated above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with the recognition and measurement principles laid down in Ind AS 34, prescribed under Section 133 of the Act, and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in accordance with the requirements of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. FOR PULINDRA PATEL & CO. CHARTERED ACCOUNTANTS FIRM REGN. NO. 115187W {‘L:Zml/e/ﬁ','/g( Place: Mumbai PULINDRA PATEL Date: 14% November, 2025 MEMBERSHIP No. 048991 CAPROLACTAM CHEMICALS LIMITED CIN : 1L24110MH1988PLC049683 UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30TH SEPTEMBER, 2025 (Rs. In Lakhs ) o I b = | 31-03-2025 | | 1| Revenue From Operetion ST PSR PPN WS O R | |Revenue from Operations |___|other Income | 23] = 009} | 232] o021] 0.96] - { OO Totalincome| 23850] 25656] 17144] 495.06]| 28393 674.91 R T e R e S IS, (L |ty SR, [, (s Ty | (a) |Cost of materials consumed 15.61 | (b) |Purchase of stock - In trade [ 144] 4.93] 37.26 84.04 m Change in inventories of Finished goods, work-in-progress and stock-intrade - - 3.75 {15.57) (15.57) [ (d) | 22.53 3699 28.41] 77.11 [ (8) | | 35038 A 208.01 743.27 | 3 |Profit/(loss)before tax(1-2) | 1033] agss| 37;a| ssss| (23.08)] 68.37) L T e A i e, W vy i (TN RS R Pibourventee I (a0 e et T | |oefered tax [ 082] 0.11 028)] 093] (044) - 250} .|l OO TotalTaxExpemses] (223)] 1234 (028)] 10a1] (04a)] 2.50] E57] | 1256] 3e21] 399] as77] (22.69) [ R S| T b VRS RS R [___[o) items That Will Not Be Reclassified ToProfitortoss T | - T - T T | 009 i (S, Sy AL PO (RS SRS Total Comprehensive Income/(Loss) for the period (5+6) ﬂ ﬂ m |8 |Details of equity share capital __= BN FEANERS T | 9 Paid-up equity share capital 460.00 | |Facevalue of equitysharecapital | 1000 1000 10.00] mﬂ [ 10.00] CR DR (T RS R I S S (T ST R [ 12 [€arnings per equity share Rs. (S e Lo (RS e | S posic | om| om| eo| tos| oam| ash L e e R [ o009 106] (0.49) (1.54) | 1000] 10.00] o isclosure of notes on finance results he above results were reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 14th November,2025 and have been w 2 o & ) =3 o o o S El = 3 a S m < ™ 3 o < pd = m > c [ = g e w 2015 (Ind AS) prescribed under Section -t = o “v © = > W - Q. o = m “w c = “w o - = - ® (o] o 3 ° o = < - Y] < ™ o o ® > o 4 o ° W 2 o o 5 o o o ° S Q. - =3 o L] £ & - o - el (2] °© 3 ° o 2 o w e - Q. w > > (2] (=] o € > = 3 ® v 2 [ -3 a ) 2 c w < F & ] - — w w o =4 - = ™ (o] o 3 o o 2 ® w > 23 n o s w o 3 Q. (=} - > ® = - o o o @« 3 N o Q. o Q o (=] c 3 = = ] o = o o = o ® “w [ 3 Q. o o a ® ©n P o - ~ ™ o x B o 3 ~ o © 3 o Y] o ® - he Standalone results of the compnay are available on the company's website http://caprolactum.co.infand also available on the websites of the BSE Ltd. And National Stock m x o - o =3 ® [ ) =X = o o = a £ = ® e o < o R a o 3 2 a o ] o a = @ o o “w el 3 X3 @ c S o “w ) ] - = o o c s 3 c “w 2 c o =3 3 ~ ] ® = ) a = 2 < ® o ® © 3 g .. ] ® =2 S [ — o m = = (o] 2 g © o) = o a £ = ] 3 < ® 2 (2] o 3 2 o ® L] (1] o ) 2 (=] n w w ] 2 ’ = = ® = Lo [ s o " 5 o A & = > w o 2 o ) c =] a ® -9 o = Py (=} - £ o o ® o, 3 o " FOR CAPROLACTAM CHEMICALS LIMITED e ey \\ i Pl R N Place: Mahad LA Mrs. Zaver S Bhanusha ) o < o “w oy S pd =5 m © = ” < =] (=3 w o < W 3 o S8 © ™ ] 3 (=% = ] < ™ o [ o 3> = o o -] (=] L= o o o X m o W w w _:., o Q. 5 (J e : A Date: 14th November, 2025 > I . : Managing Director 54 Total non-current liabilities Current liabilities Financial liabilitics . 43.77 : 18.07 Employees Benefit obligation 5.9 5.97 Total current liabilities 1,000.59 939.15 Total liabilities 945.57 Total equity and liablities 1,539.57 1,428.4 FOR CAPROLACTAM CHEMICALS LIMITED U i Place: Mahad iy ¢ "\ Kirs. Zaver S Bhanushali Date: 14th November, 2025 - : ! Managing Director e Ia DIN- 00663374

Metric	Value (₹ Cr)	Q1 FY26	Q2 FY25
Revenue	2.36	7.9%	37.9%
Total Income	2.38	7.0%	39.1%
Expenditure	2.28	9.7%	36.1%
PBT	0.10	78.7%	179.2%
Net Profit	0.13	65.3%	214.0%
OPM	27.90%	12.94pp	57.26pp
NPM	5.27%	8.84pp	2.94pp
EPS	0.27	65.8%	200.0%

CAPROLACTAM CHEMICALS LTD. Q2 FY26 Results